Immunoexpression of Programmed Death-1 Receptor (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Non-Small-Cell Lung Carcinoma and Its Correlation With Other Clinicopathological Parameters: A Cross-Sectional Study From North India

Aim To study the prevalence of programmed death-1 receptor (PD-1) and programmed death-ligand 1 (PD-L1) positive cases in non-small-cell lung carcinoma (NSCLC) and their association with other clinicopathological parameters in a tertiary care setting in North India. Material and methods One hundred...

Descripción completa

Detalles Bibliográficos
Autores principales: Anthony, Michael L, Chowdhury, Nilotpal, Mishra, Mayank, Tale, Sudheer, Arathi, Kunnumbrath, Rao, Shalinee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217682/
https://www.ncbi.nlm.nih.gov/pubmed/35755570
http://dx.doi.org/10.7759/cureus.25243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217682/
https://www.ncbi.nlm.nih.gov/pubmed/35755570
http://dx.doi.org/10.7759/cureus.25243

Ejemplares similares